Effects of Ellagic Acid on Glucose and Lipid Metabolism: A Systematic Review and Meta-Analysis.

IF 2.3 Q3 NUTRITION & DIETETICS Journal of Nutrition and Metabolism Pub Date : 2024-06-17 eCollection Date: 2024-01-01 DOI:10.1155/2024/5558665
Xuelian Wang, Xiaotao Zhou, Xinxia Zhang
{"title":"Effects of Ellagic Acid on Glucose and Lipid Metabolism: A Systematic Review and Meta-Analysis.","authors":"Xuelian Wang, Xiaotao Zhou, Xinxia Zhang","doi":"10.1155/2024/5558665","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Abnormal glucose and lipid metabolism (GALM) serve as both a cause and an inducer for the development of the disease. Improvement and treatment of GALM are an important stage to prevent the occurrence and development of the disease. However, current clinical treatment for GALM is limited. Ellagic acid (EA), a common polyphenol present in foods, has been shown to improve abnormalities in GALM observed in patients suffering from metabolic diseases.</p><p><strong>Objective: </strong>This study used a meta-analysis method to systematically assess the effects of EA on GALM.</p><p><strong>Method: </strong>As of November 8, 2023, a comprehensive search was conducted across 5 databases, namely, PubMed, Embase, Web of Science, Cochrane Library, and Google Scholar to identify randomized controlled trials (RCTs) in which EA served as the primary intervention for diseases related to GALM. The risk of bias within the included studies was assessed according to the Cochrane Handbook. All statistical analyzes were performed using RevMan 5.4 software.</p><p><strong>Results: </strong>In this study, a total of 482 articles were retrieved, resulting in the inclusion of 10 RCTs in the meta-analysis. The results showed that EA could reduce fasting blood glucose (FBG) (<i>p</i> = 0.008), increase insulin secretion (<i>p</i> = 0.01), improve insulin resistance index (HOMA-IR) (<i>p</i> = 0.003), decrease triglyceride (TG) (<i>p</i> = 0.004), and reduce cholesterol (Chol) (<i>p</i> = 0.04) and low-density lipoprotein (LDL-c) (<i>p</i> = 0.0004). EA had no significant effect on waist circumference (WC), body weight (BW), body mass index (BMI), 2 hours after prandial blood glucose (2 h-PG), total cholesterol (TC), and high-density lipoprotein (HDL-c).</p><p><strong>Conclusions: </strong>The effect of improvement in glucose and lipids of EA was closely related to the dose and the intervention time. EA can improve GALM caused by diseases. To corroborate the findings of this study and improve the reliability of the results, EA is imperative to refine the research methodology and increase the sample size in future investigations.</p>","PeriodicalId":16587,"journal":{"name":"Journal of Nutrition and Metabolism","volume":"2024 ","pages":"5558665"},"PeriodicalIF":2.3000,"publicationDate":"2024-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11196188/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nutrition and Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2024/5558665","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Abnormal glucose and lipid metabolism (GALM) serve as both a cause and an inducer for the development of the disease. Improvement and treatment of GALM are an important stage to prevent the occurrence and development of the disease. However, current clinical treatment for GALM is limited. Ellagic acid (EA), a common polyphenol present in foods, has been shown to improve abnormalities in GALM observed in patients suffering from metabolic diseases.

Objective: This study used a meta-analysis method to systematically assess the effects of EA on GALM.

Method: As of November 8, 2023, a comprehensive search was conducted across 5 databases, namely, PubMed, Embase, Web of Science, Cochrane Library, and Google Scholar to identify randomized controlled trials (RCTs) in which EA served as the primary intervention for diseases related to GALM. The risk of bias within the included studies was assessed according to the Cochrane Handbook. All statistical analyzes were performed using RevMan 5.4 software.

Results: In this study, a total of 482 articles were retrieved, resulting in the inclusion of 10 RCTs in the meta-analysis. The results showed that EA could reduce fasting blood glucose (FBG) (p = 0.008), increase insulin secretion (p = 0.01), improve insulin resistance index (HOMA-IR) (p = 0.003), decrease triglyceride (TG) (p = 0.004), and reduce cholesterol (Chol) (p = 0.04) and low-density lipoprotein (LDL-c) (p = 0.0004). EA had no significant effect on waist circumference (WC), body weight (BW), body mass index (BMI), 2 hours after prandial blood glucose (2 h-PG), total cholesterol (TC), and high-density lipoprotein (HDL-c).

Conclusions: The effect of improvement in glucose and lipids of EA was closely related to the dose and the intervention time. EA can improve GALM caused by diseases. To corroborate the findings of this study and improve the reliability of the results, EA is imperative to refine the research methodology and increase the sample size in future investigations.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
鞣花酸对葡萄糖和脂质代谢的影响:系统回顾与元分析》。
背景:糖脂代谢异常(GALM)既是疾病发生的原因,也是诱因。改善和治疗 GALM 是预防疾病发生和发展的重要阶段。然而,目前临床上治疗 GALM 的方法有限。鞣花酸(EA)是一种存在于食物中的常见多酚,已被证明可改善代谢性疾病患者的 GALM 异常:本研究采用荟萃分析法系统评估了 EA 对 GALM 的影响:截至2023年11月8日,我们对PubMed、Embase、Web of Science、Cochrane Library和Google Scholar等5个数据库进行了全面检索,以确定EA作为GALM相关疾病主要干预措施的随机对照试验(RCT)。根据 Cochrane 手册评估了纳入研究的偏倚风险。所有统计分析均使用 RevMan 5.4 软件进行:本研究共检索到 482 篇文章,最终将 10 项研究纳入荟萃分析。结果显示,EA能降低空腹血糖(FBG)(p = 0.008),增加胰岛素分泌(p = 0.01),改善胰岛素抵抗指数(HOMA-IR)(p = 0.003),降低甘油三酯(TG)(p = 0.004),降低胆固醇(Chol)(p = 0.04)和低密度脂蛋白(LDL-c)(p = 0.0004)。EA 对腰围(WC)、体重(BW)、体重指数(BMI)、餐后 2 小时血糖(2 h-PG)、总胆固醇(TC)和高密度脂蛋白(HDL-c)没有明显影响:EA改善血糖和血脂的效果与剂量和干预时间密切相关。EA 可以改善由疾病引起的 GALM。为了证实本研究的结果并提高结果的可靠性,在今后的研究中,必须完善 EA 的研究方法并增加样本量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Nutrition and Metabolism
Journal of Nutrition and Metabolism NUTRITION & DIETETICS-
CiteScore
5.40
自引率
0.00%
发文量
49
审稿时长
17 weeks
期刊介绍: Journal of Nutrition and Metabolism is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies covering the broad and multidisciplinary field of human nutrition and metabolism. The journal welcomes submissions on studies related to obesity, diabetes, metabolic syndrome, molecular and cellular biology of nutrients, foods and dietary supplements, as well as macro- and micronutrients including vitamins and minerals.
期刊最新文献
Effects of Tocotrienol on Cardiovascular Risk Markers in Patients With Chronic Kidney Disease: A Randomized Controlled Trial. Glutamine Supplementation: A Possible Strategy to Help Mitigate Health Risks of Heat-Related Illness. The Effect of Grouper Bone Nano-Calcium (GBN) and Medium-Chain Triglyceride (MCT) Supplementation on the Ovariectomized Rats. Perceptual Health and Wellbeing, Self-Reported Sleep, and Hydration Status in Youth Soccer Players During Competition. Exploring the Role of Licorice and Its Derivatives in Cell Signaling Pathway NF-κB and MAPK.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1